http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022150656-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1af3bb379f607b4e012d05a8d09b4998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa9814ed0af3a915adb6e1201eeee8bc |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-115 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02 |
| filingDate | 2022-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d85d7b0bf2db936ad37771a0ebbbd1e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5b718e7b8ecdf7b62dc0f62e4a5ce48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd6813ddd13ab171fc72437f72997856 |
| publicationDate | 2022-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022150656-A1 |
| titleOfInvention | Blood glucose control and anti-obesity probiotics compositions in a specific selection and ratio |
| abstract | One or more predetermined combination of human use (e.g., including animals) probiotics and specific ranges of ratio of anti-obesity human use probiotics compositions and their preparation methods and uses are provided. Particularly, the Present Disclosure provides a specific composition of food-grade probiotics been shaped by germ-free or antibiotics-treated dual-specificity phosphatase 6 (Dusp6) deficient mammal, which is effective in altering a relative abundance of gut microbiota and also useful in reducing body weight, fat mass, and/or size of adipocytes and increasing oxygen consumption and/or energy expenditure and thus can be used to treat or prevent obesity, manage blood glucose level, or their associated metabolic disorders or conditions in a subject in need. |
| priorityDate | 2021-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.